# Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

> **NCT07118800** · PHASE3 · NOT_YET_RECRUITING · sponsor: **UNICANCER** · enrollment: 160 (estimated)

## Conditions studied

- Locally Advanced Rectal Adenocarcinoma

## Interventions

- **DRUG:** FOLFOX4s
- **RADIATION:** Short Course Radiotherapy

## Key facts

- **NCT ID:** NCT07118800
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2030-12-15
- **Final completion:** 2032-01-15
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118800, "Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT07118800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
